Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
暂无分享，去创建一个
H. Gschaidmeier | O. Ottmann | M. Bornhäuser | B. Wassmann | M. Stelljes | J. Beck | N. Goekbuget | P. Brück | A. Binckebanck | R. Reutzel | Albrecht Reichle | Dieter Hoelzer | Stefan Schwartz | Martin Kaufmann | Lothar Kanz | D. Hoelzer | Dietrich W. Beelen | Heike Pfeifer | Jolanta Perz | Rainer Haas | Arnold Ganser | Mathias Schmid | Georg Lenz | A. Reichle